This inventor holds 1 USPTO granted patent and 16 published patent applications. Top assignees: Lawrence Livermore National Security, LLC, Leidos Biomedical Research, Inc., Theras, Inc.. Active years: 2026.
Company Filing History:
1 out of 1,621 
1 out of 4 
1 out of 1 Years Active: 2026
Title: Eli Wallace: Innovator in Cancer Treatment
Introduction
Eli Wallace is a notable inventor based in Loveland, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancers. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Eli Wallace holds a patent for "Compositions and methods for inhibition of RAS." This patent includes compounds, salts, esters, tautomers, prodrugs, zwitterionic forms, or stereoisomers, along with pharmaceutical compositions that utilize these compounds. The methods described in the patent focus on modulating, specifically inhibiting, KRAS, particularly the KRAS variant with a G12C mutation. This innovation is aimed at treating diseases or disorders such as cancers in patients who require effective therapeutic options. Eli Wallace has 1 patent to his name.
Career Highlights
Throughout his career, Eli has worked with prominent organizations, including Leidos Biomedical Research, Inc. and Lawrence Livermore National Security, LLC. His experience in these companies has allowed him to develop and refine his innovative ideas in the biomedical field.
Collaborations
Eli has collaborated with talented individuals such as Yue Yang and Dhirendra Kumar Simanshu. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Eli Wallace is a dedicated inventor whose work in cancer treatment showcases his commitment to improving healthcare through innovation. His patent for inhibiting RAS represents a significant step forward in the fight against cancer.